Our present study expands on prior research by revealing clear relationships between MBI-apathy and the complete range of CSF biomarkers outlined in the NIA-AA research framework for AD.8 Additionally, our findings for the non-apathy MBI group underscore the presence of early pathological changes associated with both amyloid and tau. This evidence concerns the gene MAPT and Alzheimer disease.